retatrutide approval 2025 is the most significant weight-loss pharmaceutical currently in clinical development., Phase 3 TRIUMPH-4 trial results (published December 2025) showed average body weight reduction of Retatrutide Peptide for Weight Loss,

Semaglutide vs Retatrutide: Clinical Trial Results Compared Semaglutide (STEP Trials) The STEP clinical trial program established semaglutide as the first incretin-based therapy to demonstrate clinically meaningful weight reduction

Enjoy this simple meal plan

Yamagishi S, Matsui T

Fras JP, Davies MJ, Rosenstock J, Prez Manghi FC, Fernndez Land L, Bergman BK, Liu B, Cui X, Brown K, for the SURPASS-2 Investigators

This removes a major barrier and makes it easier to take the first step toward a patients health goals

It focuses on brand-name GLP-1s, optional workshops, and insurance support, with plans starting at $25 , making it different from medication-first clinics